计算溶液所需的质量、体积或浓度。
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
A126103-5mg |
5mg |
现货 ![]() |
| |
A126103-10mg |
10mg |
现货 ![]() |
| |
A126103-25mg |
25mg |
现货 ![]() |
| |
A126103-50mg |
50mg |
现货 ![]() |
| |
A126103-100mg |
100mg |
现货 ![]() |
| |
A126103-250mg |
250mg |
现货 ![]() |
|
别名 | 阿那匹韦 |
---|---|
英文别名 | BMS650032 | HY-14434 | D10093 | N-(Tert-Butoxycarbonyl)-3-Methyl-L-Valyl-(4r)-4-[(7-Chloro-4-Methoxyisoquinolin-1-Yl)oxy]-N-{(1r,2s)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-Ethenylcyclopropyl}-L-Prolinamide | compound 24 [PMID: 24564672] | UNII-S9X0KRJ00S | |
规格或纯度 | Moligand™, ≥98% |
英文名称 | Asunaprevir |
生化机理 | Asunaprevir 是病毒丝氨酸蛋白酶 HCV NS3 的抑制剂。 |
储存温度 | -20°C储存,充氩 |
运输条件 | 超低温冰袋运输 |
作用类型 | 抑制剂 |
作用机制 | 丙型肝炎病毒丝氨酸蛋白酶、NS3/NS4A 抑制剂 |
产品介绍 |
Asunaprevir (BMS-650032) is a potent hepatitis C virus (HCV) NS3 protease inhibitor.An inhibitor of the viral enzyme serine protease HCV NS3. Asunaprevir (BMS-650032) is a potent hepatitis C virus (HCV) NS3 protease inhibitor. |
ALogP | 4.9 |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504768030 |
---|---|
分子类型 | 小分子 |
IUPAC Name | tert-butyl N-[(2S)-1-[(2S,4R)-4-(7-chloro-4-methoxyisoquinolin-1-yl)oxy-2-[[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate |
INCHI | InChI=1S/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1 |
InChi Key | XRWSZZJLZRKHHD-WVWIJVSJSA-N |
Canonical SMILES | CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C |
Isomeric SMILES | CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C |
PubChem CID | 16076883 |
分子量 | 748.29 |
溶解性 | Soluble in DMSO. |
---|---|
分子量 | 748.300 g/mol |
XLogP3 | 4.900 |
氢键供体数Hydrogen Bond Donor Count | 3 |
氢键受体数Hydrogen Bond Acceptor Count | 10 |
可旋转键计数Rotatable Bond Count | 14 |
精确质量Exact Mass | 747.27 Da |
单同位素质量Monoisotopic Mass | 747.27 Da |
拓扑极表面积Topological Polar Surface Area | 191.000 Ų |
重原子数Heavy Atom Count | 51 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 1470.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 5 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
Nitrogen by Elemental Analysis | 8.5-10.5(%) |
---|---|
Carbon by Elemental Analysis | 54.5-56.9(%) |
Purity(HPLC) | 98-100(%) |
Appearance(A126103) | White to off-white solid |
NMR spectrum | Conforms to Structure |
1. Scola PM, Sun LQ, Wang AX, Chen J, Sin N, Venables BL, Sit SY, Chen Y, Cocuzza A, Bilder DM et al.. (2014) The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection.. J Med Chem, 57 (5): (1730-52). [PMID:24564672] [10.1021/op500134e] |
2. Akamatsu N, Sugawara Y, Kokudo N. (2015) Asunaprevir (BMS-650032) for the treatment of hepatitis C virus.. Expert Rev Anti Infect Ther, 13 (11): (1307-17). [PMID:26414905] [10.1021/op500134e] |